NovaBridge Biosciences
NASDAQ:NBP · NASDAQ Global Market
-$0.07 today
Vol 0.65M · Avg 0.90M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-39.02%
Period High
$6.56
Period Low
$1.47
Latest
$1.50
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$862.31M
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$849.40M
Design Therapeutics, Inc.
NASDAQ:DSGN
$766.03M
Annexon, Inc.
NASDAQ:ANNX
$588.41M
Aura Biosciences, Inc.
NASDAQ:AURA
$397.72M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$355.43M
DiaMedica Therapeutics Inc.
NASDAQ:DMAC
$307.40M
Altimmune, Inc.
NASDAQ:ALT
$240.97M
Galectin Therapeutics Inc.
NASDAQ:GALT
$185.39M
enGene Holdings Inc.
NASDAQ:ENGN
$88.06M
What is the latest NBP filing?
The latest filing shown is 20-F/A dated Jun 16, 2026.
How many recent filings does NBP have?
Intrinsic Alpha currently shows 20 recent filings for NBP.
Explore More
Continue the stock analysis
Jump to another research area for this company.